![RCY RCY](https://data.pdbj.org/pdbjplus/data/cc/svg/RCY.svg) | RCY | 表記: | (3'R)-1'-oxyl-2',2',5',5'-tetramethyl-1,3'-bipyrrolidine-2,5-dione | 組成式: | C12 H19 N2 O3 | SMILES: | ON2C(CC(N1C(=O)CCC1=O)C2(C)C)(C)C | InChi: | InChI=1S/C12H20N2O3/c1-11(2)7-8(12(3,4)14(11)17)13-9(15)5-6-10(13)16/h8,17H,5-7H2,1-4H3/t8-/m1/s1 | 別名: | 3-Maleimido-PROXYL (bound form) | 定義日: | 2007-10-05 | 最終更新日: | 2020-06-17 | 識別子(ID): | (3'R)-1'-hydroxy-2',2',5',5'-tetramethyl-1,3'-bipyrrolidine-2,5-dione |
|
![RDC RDC](https://data.pdbj.org/pdbjplus/data/cc/svg/RDC.svg) | RDC | 表記: | RADICICOL | 組成式: | C18 H17 Cl O6 | SMILES: | O=C2C=CC=CC3OC3CC(OC(=O)c1c(O)cc(O)c(Cl)c1C2)C | InChi: | InChI=1S/C18H17ClO6/c1-9-6-15-14(25-15)5-3-2-4-10(20)7-11-16(18(23)24-9)12(21)8-13(22)17(11)19/h2-5,8-9,14-15,21-22H,6-7H2,1H3/b4-2+,5-3-/t9-,14-,15-/m1/s1 | 別名: | MONORDEN | 定義日: | 1999-07-08 | 最終更新日: | 2020-06-17 | 識別子(ID): | (1aR,2Z,4E,14R,15aR)-8-chloro-9,11-dihydroxy-14-methyl-1a,14,15,15a-tetrahydro-6H-oxireno[e][2]benzoxacyclotetradecine-6,12(7H)-dione |
|
![RDG RDG](https://data.pdbj.org/pdbjplus/data/cc/svg/RDG.svg) | RDG | 表記: | 2'-deoxy-N-(furan-2-ylmethyl)guanosine 5'-(dihydrogen phosphate) | 組成式: | C15 H18 N5 O8 P | SMILES: | O=P(O)(O)OCC4OC(n3cnc2c3N=C(NCc1occc1)NC2=O)CC4O | InChi: | InChI=1S/C15H18N5O8P/c21-9-4-11(28-10(9)6-27-29(23,24)25)20-7-17-12-13(20)18-15(19-14(12)22)16-5-8-2-1-3-26-8/h1-3,7,9-11,21H,4-6H2,(H2,23,24,25)(H2,16,18,19,22)/t9-,10+,11+/m0/s1 | 別名: | N2-furfuryl-deoxyguanosine-5'-monophosphate | 定義日: | 2013-04-22 | 最終更新日: | 2020-06-17 | 公開日: | 2015-05-06 | 識別子(ID): | 2'-deoxy-N-(furan-2-ylmethyl)guanosine 5'-(dihydrogen phosphate) |
|
![95H 95H](https://data.pdbj.org/pdbjplus/data/cc/svg/95H.svg) | 95H | 表記: | ~{N}-[(1~{R},2~{R})-1-[(2~{R},3~{R},4~{S},5~{R},6~{R})-6-methylsulfanyl-3,4,5-tris(oxidanyl)oxan-2-yl]-2-oxidanyl-propy
l]-4-nitro-benzamide | 組成式: | C16 H22 N2 O8 S | SMILES: | CS[CH]1O[CH]([CH](O)[CH](O)[CH]1O)[CH](NC(=O)c2ccc(cc2)[N+]([O-])=O)[CH](C)O | InChi: | InChI=1S/C16H22N2O8S/c1-7(19)10(14-12(21)11(20)13(22)16(26-14)27-2)17-15(23)8-3-5-9(6-4-8)18(24)25/h3-7,10-14,16,19-22H,1-2H3,(H,17,23)/t7-,10-,11+,12-,13-,14-,16-/m1/s1 | 別名: | RB02 | 定義日: | 2017-04-23 | 最終更新日: | 2020-06-17 | 公開日: | 2017-08-09 | 識別子(ID): | ~{N}-[(1~{R},2~{R})-1-[(2~{R},3~{R},4~{S},5~{R},6~{R})-6-methylsulfanyl-3,4,5-tris(oxidanyl)oxan-2-yl]-2-oxidanyl-propyl]-4-nitro-benzamide |
|
![961 961](https://data.pdbj.org/pdbjplus/data/cc/svg/961.svg) | 961 | 表記: | 3-FLUORO-4-[2-HYDROXY-2-(5,5,8,8-TETRAMETHYL-5,6,7,8,-TETRAHYDRO-NAPHTALEN-2-YL)-ACETYLAMINO]-BENZOIC ACID | 組成式: | C23 H26 F N O4 | SMILES: | O=C(O)c1ccc(c(F)c1)NC(=O)C(O)c2ccc3c(c2)C(CCC3(C)C)(C)C | InChi: | InChI=1S/C23H26FNO4/c1-22(2)9-10-23(3,4)16-11-13(5-7-15(16)22)19(26)20(27)25-18-8-6-14(21(28)29)12-17(18)24/h5-8,11-12,19,26H,9-10H2,1-4H3,(H,25,27)(H,28,29)/t19-/m0/s1 | 別名: | BMS961 | 定義日: | 1999-07-08 | 最終更新日: | 2020-06-17 | 識別子(ID): | 3-fluoro-4-{[(2S)-2-hydroxy-2-(5,5,8,8-tetramethyl-5,6,7,8-tetrahydronaphthalen-2-yl)acetyl]amino}benzoic acid |
|
![964 964](https://data.pdbj.org/pdbjplus/data/cc/svg/964.svg) | 964 | 表記: | 3-(4-{2-[2-(2-BROMO-ACETYLAMINO)-ETHYLDISULFANYL]-ETHYLCARBAMOYL}-CYCLOHEXYLCARBAMOYL)-PYRAZINE-2-CARBOXYLIC ACID | 組成式: | C19 H27 N5 O5 S2 | SMILES: | O=C(c1nccnc1C(=O)O)NC2CCC(C(=O)NCCSSCCNC(=O)C)CC2 | InChi: | InChI=1S/C19H27N5O5S2/c1-12(25)20-8-10-30-31-11-9-23-17(26)13-2-4-14(5-3-13)24-18(27)15-16(19(28)29)22-7-6-21-15/h6-7,13-14H,2-5,8-11H2,1H3,(H,20,25)(H,23,26)(H,24,27)(H,28,29)/t13-,14+ | 別名: | SP7343-SP7964 | 定義日: | 2003-02-21 | 最終更新日: | 2020-06-17 | 識別子(ID): | 3-({cis-4-[(2-{[2-(acetylamino)ethyl]disulfanyl}ethyl)carbamoyl]cyclohexyl}carbamoyl)pyrazine-2-carboxylic acid |
|
![REC REC](https://data.pdbj.org/pdbjplus/data/cc/svg/REC.svg) | REC | 表記: | CEPHALOSPORIN | 組成式: | C15 H21 N3 O7 S | SMILES: | O=C(O)C(N)CCCCC(=O)NC(C(=O)O)C1N=C(C(=C)CS1)C(=O)O | InChi: | InChI=1S/C15H21N3O7S/c1-7-6-26-12(18-10(7)14(22)23)11(15(24)25)17-9(19)5-3-2-4-8(16)13(20)21/h8,11-12H,1-6,16H2,(H,17,19)(H,20,21)(H,22,23)(H,24,25)/t8-,11+,12-/m1/s1 | 別名: | (2R)-2-[(R)-{[(6R)-6-amino-6-carboxyhexanoyl]amino}(carboxy)methyl]-5-methylidene-5,6-dihydro-2H-1,3-thiazine-4-carboxy
lic acid | 定義日: | 2007-11-14 | 最終更新日: | 2020-06-17 | 識別子(ID): | (2R)-2-[(R)-{[(6R)-6-amino-6-carboxyhexanoyl]amino}(carboxy)methyl]-5-methylidene-5,6-dihydro-2H-1,3-thiazine-4-carboxylic acid |
|
![REF REF](https://data.pdbj.org/pdbjplus/data/cc/svg/REF.svg) | REF | 表記: | 2,3,7,8-tetrahydroxychromeno[5,4,3-cde]chromene-5,10-dione | 組成式: | C14 H6 O8 | SMILES: | O=C1Oc3c2c4c1cc(O)c(O)c4OC(=O)c2cc(O)c3O | InChi: | InChI=1S/C14H6O8/c15-5-1-3-7-8-4(14(20)22-11(7)9(5)17)2-6(16)10(18)12(8)21-13(3)19/h1-2,15-18H | 別名: | Ellagic acid, 4,4',5,5',6,6'-Hexahydroxydiphenic acid 2,6,2',6'-dilactone | 定義日: | 2008-03-12 | 最終更新日: | 2020-06-17 | 識別子(ID): | 2,3,7,8-tetrahydroxychromeno[5,4,3-cde]chromene-5,10-dione |
|
![REN REN](https://data.pdbj.org/pdbjplus/data/cc/svg/REN.svg) | REN | 表記: | (S)-reticuline | 組成式: | C19 H23 N O4 | SMILES: | O(c1ccc(cc1O)CC3c2c(cc(OC)c(O)c2)CCN3C)C | InChi: | InChI=1S/C19H23NO4/c1-20-7-6-13-10-19(24-3)17(22)11-14(13)15(20)8-12-4-5-18(23-2)16(21)9-12/h4-5,9-11,15,21-22H,6-8H2,1-3H3/t15-/m0/s1 | 別名: | (1S)-1-(3-hydroxy-4-methoxybenzyl)-6-methoxy-2-methyl-1,2,3,4-tetrahydroisoquinolin-7-ol | 定義日: | 2008-06-04 | 最終更新日: | 2020-06-17 | 識別子(ID): | (1S)-1-(3-hydroxy-4-methoxybenzyl)-6-methoxy-2-methyl-1,2,3,4-tetrahydroisoquinolin-7-ol |
|
![96N 96N](https://data.pdbj.org/pdbjplus/data/cc/svg/96N.svg) | 96N | 表記: | 4-ethanoyl-3-ethyl-5-methyl-~{N}-(naphthalen-1-ylmethyl)-1~{H}-pyrrole-2-carboxamide | 組成式: | C21 H22 N2 O2 | SMILES: | CCc1c([nH]c(C)c1C(C)=O)C(=O)NCc2cccc3ccccc23 | InChi: | InChI=1S/C21H22N2O2/c1-4-17-19(14(3)24)13(2)23-20(17)21(25)22-12-16-10-7-9-15-8-5-6-11-18(15)16/h5-11,23H,4,12H2,1-3H3,(H,22,25) | 別名: | XDM4 | 定義日: | 2017-04-25 | 最終更新日: | 2020-06-17 | 公開日: | 2017-08-16 | 識別子(ID): | 4-ethanoyl-3-ethyl-5-methyl-~{N}-(naphthalen-1-ylmethyl)-1~{H}-pyrrole-2-carboxamide |
|
![REW REW](https://data.pdbj.org/pdbjplus/data/cc/svg/REW.svg) | REW | 表記: | (2S,3S)-1-(4-METHOXYPHENYL)-3-(3-(2-(5-METHYL-2-PHENYLOXAZOL-4-YL)ETHOXY)BENZYL)-4-OXOAZETIDINE-2-CARBOXYLIC ACID | 組成式: | C30 H28 N2 O6 | SMILES: | O=C(O)C2N(c1ccc(OC)cc1)C(=O)C2Cc5cc(OCCc3nc(oc3C)c4ccccc4)ccc5 | InChi: | InChI=1S/C30H28N2O6/c1-19-26(31-28(38-19)21-8-4-3-5-9-21)15-16-37-24-10-6-7-20(17-24)18-25-27(30(34)35)32(29(25)33)22-11-13-23(36-2)14-12-22/h3-14,17,25,27H,15-16,18H2,1-2H3,(H,34,35)/t25-,27-/m0/s1 | 別名: | 4-[2-(3-{[(2S,3S)-2-carboxy-1-(4-methoxyphenyl)-4-oxoazetidin-3-yl]methyl}phenoxy)ethyl]-5-methyl-2-phenyl-1,3-oxazol-3
-ium | 定義日: | 2007-10-30 | 最終更新日: | 2020-06-17 | 識別子(ID): | (2S,3S)-1-(4-methoxyphenyl)-3-{3-[2-(5-methyl-2-phenyl-1,3-oxazol-4-yl)ethoxy]benzyl}-4-oxoazetidine-2-carboxylic acid |
|
![96V 96V](https://data.pdbj.org/pdbjplus/data/cc/svg/96V.svg) | 96V | 表記: | N,2-dimethyl-7-oxo-N-{1-[(1S)-1-phenylethyl]piperidin-4-yl}-6-(prop-2-en-1-yl)-6,7-dihydro-1H-pyrrolo[2,3-c]pyridine-4-
carboxamide | 組成式: | C26 H32 N4 O2 | SMILES: | c12C(=CN(C(c1nc(c2)C)=O)CC=C)C(=O)N(C)C3CCN(CC3)C(c4ccccc4)C | InChi: | InChI=1S/C26H32N4O2/c1-5-13-30-17-23(22-16-18(2)27-24(22)26(30)32)25(31)28(4)21-11-14-29(15-12-21)19(3)20-9-7-6-8-10-20/h5-10,16-17,19,21,27H,1,11-15H2,2-4H3/t19-/m0/s1 | 別名: | 6-allyl-N,2-dimethyl-7-oxo-N-(1-(1-phenylethyl)piperidin-4-yl)-6,7-dihydro-1H-pyrrolo[2,3-c]pyridine-4-carboxamide | 定義日: | 2017-04-04 | 最終更新日: | 2020-06-17 | 公開日: | 2017-06-14 | 識別子(ID): | N,2-dimethyl-7-oxo-N-{1-[(1S)-1-phenylethyl]piperidin-4-yl}-6-(prop-2-en-1-yl)-6,7-dihydro-1H-pyrrolo[2,3-c]pyridine-4-carboxamide |
|
![971 971](https://data.pdbj.org/pdbjplus/data/cc/svg/971.svg) | 971 | 表記: | 1-methyl-4-{3-[6-(piperazin-1-yl)pyridin-2-yl]-1H-pyrazolo[3,4-c]pyridin-5-yl}piperazin-2-one | 組成式: | C20 H24 N8 O | SMILES: | C5(CN(c1ncc2c(c1)c(nn2)c3cccc(n3)N4CCNCC4)CCN5C)=O | InChi: | InChI=1S/C20H24N8O/c1-26-9-10-28(13-19(26)29)18-11-14-16(12-22-18)24-25-20(14)15-3-2-4-17(23-15)27-7-5-21-6-8-27/h2-4,11-12,21H,5-10,13H2,1H3,(H,24,25) | 別名: | Cpd1 | 定義日: | 2017-04-04 | 最終更新日: | 2020-06-17 | 公開日: | 2018-04-18 | 識別子(ID): | 1-methyl-4-{3-[6-(piperazin-1-yl)pyridin-2-yl]-1H-pyrazolo[3,4-c]pyridin-5-yl}piperazin-2-one |
|
![972 972](https://data.pdbj.org/pdbjplus/data/cc/svg/972.svg) | 972 | 表記: | 2-{5-[AMINO(IMINIO)METHYL]-6-CHLORO-1H-BENZIMIDAZOL-2-YL}-6-ISOBUTOXYBENZENOLATE | 組成式: | C18 H19 Cl N4 O2 | SMILES: | [O-]c3c(OCC(C)C)cccc3c2nc1cc(c(Cl)cc1n2)C(=[NH2+])N | InChi: | InChI=1S/C18H19ClN4O2/c1-9(2)8-25-15-5-3-4-10(16(15)24)18-22-13-6-11(17(20)21)12(19)7-14(13)23-18/h3-7,9,24H,8H2,1-2H3,(H3,20,21)(H,22,23) | 別名: | CRA_10972 | 定義日: | 2003-03-14 | 最終更新日: | 2020-06-17 | 識別子(ID): | 2-{5-[amino(iminio)methyl]-6-chloro-1H-benzimidazol-2-yl}-6-(2-methylpropoxy)phenolate |
|
![RFC RFC](https://data.pdbj.org/pdbjplus/data/cc/svg/RFC.svg) | RFC | 表記: | (R)-IBUPROFENOYL-COENZYME A | 組成式: | C34 H53 N7 O17 P3 S | SMILES: | O=C(SCCNC(=O)CCNC(=O)C(O)C(C)(C)COP(=O)(O)OP(=O)(O)OCC3OC([n+]2cnc1c2ncnc1N)C(O)C3OP(=O)(O)O)C(c4ccc(cc4)CC(C)C)C | InChi: | InChI=1S/C34H52N7O17P3S/c1-19(2)14-21-6-8-22(9-7-21)20(3)33(46)62-13-12-36-24(42)10-11-37-31(45)28(44)34(4,5)16-55-61(52,53)58-60(50,51)54-15-23-27(57-59(47,48)49)26(43)32(56-23)41-18-40-25-29(35)38-17-39-30(25)41/h6-9,17-20,23,26-28,32,43-44H,10-16H2,1-5H3,(H8,35,36,37,38,39,42,45,47,48,49,50,51,52,53)/p+1/t20-,23-,26-,27-,28+,32-/m1/s1 | 別名: | [5-(6-AMINOPURIN-9-YL)-2-[[[[3-[2-(2-(R)-2-[4-(2-METHYLPROPYL)PHENYL] PROPANOYL)-SULFANYLETHYLCARBAMOYL
ETHYLCARBAMOYL]-3-HYDROXY-2,2-DIMETHYL-PROPOXY]-HYDROXY-PHOSPHORYL]OXY-HYDROXY-PHOSPHORYL]OXYMETHYL]-4-HYDROXY-OXOLAN-3-
YL]OXYPHOSPHONIC ACID | 定義日: | 2006-03-23 | 最終更新日: | 2020-06-17 | 識別子(ID): | 6-amino-9-[(2R,3R,4S,5R)-3-hydroxy-4-(phosphonooxy)-5-{(3S,5R,9R,20R)-3,5,9-trihydroxy-8,8-dimethyl-20-[4-(2-methylpropyl)phenyl]-3,5-dioxido-10,14,19-trioxo-2,4,6-trioxa-18-thia-11,15-diaza-3,5-diphosphahenicos-1-yl}tetrahydrofuran-2-yl]-7H-purin-9-ium (non-preferred name) |
|
![RFS RFS](https://data.pdbj.org/pdbjplus/data/cc/svg/RFS.svg) | RFS | 表記: | Br-paroxetine | 組成式: | C19 H20 Br N O3 | SMILES: | c4(ccc(C1CCNCC1COc2cc3c(cc2)OCO3)cc4)Br | InChi: | InChI=1S/C19H20BrNO3/c20-15-3-1-13(2-4-15)17-7-8-21-10-14(17)11-22-16-5-6-18-19(9-16)24-12-23-18/h1-6,9,14,17,21H,7-8,10-12H2/t14-,17-/m0/s1 | 別名: | (3S,4R)-3-{[(2H-1,3-benzodioxol-5-yl)oxy]methyl}-4-(4-bromophenyl)piperidine | 定義日: | 2020-02-11 | 最終更新日: | 2020-06-17 | 公開日: | 2020-03-11 | 識別子(ID): | (3S,4R)-3-{[(2H-1,3-benzodioxol-5-yl)oxy]methyl}-4-(4-bromophenyl)piperidine |
|
![RG1 RG1](https://data.pdbj.org/pdbjplus/data/cc/svg/RG1.svg) | RG1 | 表記: | Rhodopin b-D-glucoside | 組成式: | C46 H66 O6 | SMILES: | C1(OC(C(C(C1O)O)O)CO)OC(C)(C)CCCC(C)=[C@H][C@H]=[C@H]C(C)=[C@H][C@H]=[C@H]C(C)=[C@H][C@H]=[C@H][C@H]=C(C)[C@H]=[C@H][C@H]=C(C)[C@H]=[C@H][C@H]=C(C)[C@H]=[C@H][C@H]=C(C)C | InChi: | InChI=1S/C46H66O6/c1-34(2)19-13-22-37(5)25-16-28-38(6)26-14-23-35(3)20-11-12-21-36(4)24-15-27-39(7)29-17-30-40(8)31-18-32-46(9,10)52-45-44(50)43(49)42(48)41(33-47)51-45/h11-17,19-30,41-45,47-50H,18,31-33H2,1-10H3/b12-11+,22-13+,23-14+,24-15+,28-16+,29-17+,35-20+,36-21+,37-25+,38-26+,39-27+,40-30+/t41-,42-,43+,44-,45+/m1/s1 | 別名: | (3E)-3,4-didehydro-1',2'-dihydro-psi,psi-caroten-1'-yl beta-D-glucopyranoside | 定義日: | 1999-07-08 | 最終更新日: | 2020-06-17 | 識別子(ID): | (3E)-3,4-didehydro-1',2'-dihydro-psi,psi-caroten-1'-yl beta-D-glucopyranoside |
|
![RGA RGA](https://data.pdbj.org/pdbjplus/data/cc/svg/RGA.svg) | RGA | 表記: | REIDISPONGIOLIDE A | 組成式: | C54 H87 N O13 | SMILES: | O=CN(C=CCC(OC)C(C(=O)CCC(C)C(OC)C(C)C1OC(=O)C=CC=C(C)CC(OC)CC2=CC(=O)OC(C(C(OC)CC(OC)C=CC(C)C(OC)CC(OC)C=CC1C)C)C2)C)C | InChi: | InChI=1S/C54H87NO13/c1-35-18-16-20-51(58)68-54(41(7)53(66-15)37(3)23-26-46(57)39(5)47(63-12)19-17-27-55(8)34-56)38(4)22-25-43(60-9)32-48(64-13)36(2)21-24-44(61-10)33-49(65-14)40(6)50-30-42(31-52(59)67-50)29-45(28-35)62-11/h16-18,20-22,24-25,27,31,34,36-41,43-45,47-50,53-54H,19,23,26,28-30,32-33H2,1-15H3/b20-16+,24-21+,25-22+,27-17+,35-18+/t36-,37-,38-,39-,40+,41-,43-,44+,45+,47+,48-,49-,50+,53-,54-/m0/s1 | 別名: | N-((E)-4,10-DIMETHOXY-5,9-DIMETHYL-6-OXO-11-((5Z,7Z,13Z,19Z)-3,15,17,21,23-PENTAMETHOXY-5,12,18,24-TETRAMETHYL-9,27-DIO
XO-10,26-DIOXABICYCLO[23.3.1]NONACOSA-1(28),5,7,13,19-PENTAEN-11-YL)DODEC-1-ENYL)-N-METHYLFORMAMIDE | 定義日: | 2005-08-30 | 最終更新日: | 2020-06-17 | 識別子(ID): | N-{(1E,4R,5R,9S,10S,11S)-4,10-dimethoxy-5,9-dimethyl-6-oxo-11-[(3R,5E,7E,11S,12S,13E,15R,17S,18S,19E,21S,23S,24R,25R)-3,15,17,21,23-pentamethoxy-5,12,18,24-tetramethyl-9,27-dioxo-10,26-dioxabicyclo[23.3.1]nonacosa-1(28),5,7,13,19-pentaen-11-yl]dodec-1-en-1-yl}-N-methylformamide |
|
![RGC RGC](https://data.pdbj.org/pdbjplus/data/cc/svg/RGC.svg) | RGC | 表記: | REIDISPONGIOLIDE C | 組成式: | C52 H84 O14 | SMILES: | O=C(O)CCC(OC)C(C(=O)CCC(C)C(OC)C(C)C1OC(=O)C=CC=C(C)CC(OC)CC2=CC(=O)OC(C(C(OC)CC(OC)C=CC(C)C(OC)CC(OC)C=CC1C)C)C2)C | InChi: | InChI=1S/C52H84O14/c1-32-16-15-17-49(56)66-52(38(7)51(64-14)34(3)20-23-43(53)36(5)44(61-11)24-25-48(54)55)35(4)19-22-40(58-8)30-45(62-12)33(2)18-21-41(59-9)31-46(63-13)37(6)47-28-39(29-50(57)65-47)27-42(26-32)60-10/h15-19,21-22,29,33-38,40-42,44-47,51-52H,20,23-28,30-31H2,1-14H3,(H,54,55)/b17-15+,21-18+,22-19+,32-16+/t33-,34-,35-,36-,37+,38-,40-,41+,42+,44+,45-,46-,47+,51-,52-/m0/s1 | 別名: | (4R,5R,9S,10S,11S)-4,10-DIMETHOXY-5,9-DIMETHYL-6-OXO-11-((3R,5Z,7Z,11S,12S,13Z,15R,17S,18S,19Z,21S,23S,24R,25R)-3,15,17
,21,23-PENTAMETHOXY-5,12,18,24-TETRAMETHYL-9,27-DIOXO-10,26-DIOXABICYCLO[23.3.1]NONACOSA-1(28),5,7,13,19-PENTAEN-11-YL)D
ODECANOIC ACID | 定義日: | 2005-08-30 | 最終更新日: | 2020-06-17 | 識別子(ID): | (4R,5R,9S,10S,11S)-4,10-dimethoxy-5,9-dimethyl-6-oxo-11-[(3R,5E,7E,11S,12S,13E,15R,17S,18S,19E,21S,23S,24R,25R)-3,15,17,21,23-pentamethoxy-5,12,18,24-tetramethyl-9,27-dioxo-10,26-dioxabicyclo[23.3.1]nonacosa-1(28),5,7,13,19-pentaen-11-yl]dodecanoic acid |
|
![RGT RGT](https://data.pdbj.org/pdbjplus/data/cc/svg/RGT.svg) | RGT | 表記: | 2-amino-9-{5-O-[(R)-hydroxy{[(R)-hydroxy(phosphonooxy)phosphoryl]oxy}phosphoryl]-beta-D-ribofuranosyl}-9H-purin-6-yl
5-O-phosphono-beta-D-ribofuranoside | 組成式: | C15 H25 N5 O21 P4 | SMILES: | O=P(O)(O)OP(=O)(O)OP(=O)(O)OCC4OC(n2cnc1c(nc(nc12)N)OC3OC(C(O)C3O)COP(=O)(O)O)C(O)C4O | InChi: | InChI=1S/C15H25N5O21P4/c16-15-18-11-6(12(19-15)39-14-10(24)8(22)5(38-14)1-35-42(25,26)27)17-3-20(11)13-9(23)7(21)4(37-13)2-36-44(31,32)41-45(33,34)40-43(28,29)30/h3-5,7-10,13-14,21-24H,1-2H2,(H,31,32)(H,33,34)(H2,16,18,19)(H2,25,26,27)(H2,28,29,30)/t4-,5-,7-,8-,9-,10-,13-,14+/m1/s1 | 別名: | (Ribose-5'-phosphate)-(guanosine-5'-triphosphate) | 定義日: | 2008-07-31 | 最終更新日: | 2020-06-17 | 識別子(ID): | 2-amino-9-{5-O-[(R)-hydroxy{[(R)-hydroxy(phosphonooxy)phosphoryl]oxy}phosphoryl]-beta-D-ribofuranosyl}-9H-purin-6-yl 5-O-phosphono-beta-D-ribofuranoside |
|
![6GT 6GT](https://data.pdbj.org/pdbjplus/data/cc/svg/6GT.svg) | 6GT | 表記: | 2-oxoheptanedioic acid | 組成式: | C7 H10 O5 | SMILES: | O=C(CCCCC(C(=O)O)=O)O | InChi: | InChI=1S/C7H10O5/c8-5(7(11)12)3-1-2-4-6(9)10/h1-4H2,(H,9,10)(H,11,12) | 別名: | 2-Ketopimelic acid | 定義日: | 2016-04-07 | 最終更新日: | 2020-06-17 | 公開日: | 2016-08-17 | 識別子(ID): | 2-oxoheptanedioic acid |
|
![PWK PWK](https://data.pdbj.org/pdbjplus/data/cc/svg/PWK.svg) | PWK | 表記: | 4,4'-[(2R,3R)-2,3-dimethylbutane-1,4-diyl]bis(2-methoxyphenol) | 組成式: | C20 H26 O4 | SMILES: | Oc1ccc(cc1OC)CC(C)C(C)Cc2ccc(O)c(OC)c2 | InChi: | InChI=1S/C20H26O4/c1-13(9-15-5-7-17(21)19(11-15)23-3)14(2)10-16-6-8-18(22)20(12-16)24-4/h5-8,11-14,21-22H,9-10H2,1-4H3/t13-,14-/m1/s1 | 別名: | Dihydroguaiaretic acid | 定義日: | 2014-04-02 | 最終更新日: | 2020-06-17 | 公開日: | 2014-11-26 | 識別子(ID): | 4,4'-[(2R,3R)-2,3-dimethylbutane-1,4-diyl]bis(2-methoxyphenol) |
|
![PX5 PX5](https://data.pdbj.org/pdbjplus/data/cc/svg/PX5.svg) | PX5 | 表記: | 4-(1,3-benzothiazol-2-yl)-4-hydroxycyclohexa-2,5-dien-1-one | 組成式: | C13 H9 N O2 S | SMILES: | O=C3C=CC(O)(c1nc2ccccc2s1)C=C3 | InChi: | InChI=1S/C13H9NO2S/c15-9-5-7-13(16,8-6-9)12-14-10-3-1-2-4-11(10)17-12/h1-8,16H | 別名: | 4-(benzothiazol-2-yl)-4-hydroxycyclohexa-2,5-dienone | 定義日: | 2010-08-30 | 最終更新日: | 2020-06-17 | 識別子(ID): | 4-(1,3-benzothiazol-2-yl)-4-hydroxycyclohexa-2,5-dien-1-one |
|
![PXB PXB](https://data.pdbj.org/pdbjplus/data/cc/svg/PXB.svg) | PXB | 表記: | parecoxib | 組成式: | C19 H18 N2 O4 S | SMILES: | O=C(NS(=O)(=O)c3ccc(c2c(onc2c1ccccc1)C)cc3)CC | InChi: | InChI=1S/C19H18N2O4S/c1-3-17(22)21-26(23,24)16-11-9-14(10-12-16)18-13(2)25-20-19(18)15-7-5-4-6-8-15/h4-12H,3H2,1-2H3,(H,21,22) | 別名: | N-{[4-(5-methyl-3-phenylisoxazol-4-yl)phenyl]sulfonyl}propanamide | 定義日: | 2008-06-17 | 最終更新日: | 2020-06-17 | 識別子(ID): | N-{[4-(5-methyl-3-phenylisoxazol-4-yl)phenyl]sulfonyl}propanamide |
|
![PXD PXD](https://data.pdbj.org/pdbjplus/data/cc/svg/PXD.svg) | PXD | 表記: | 2-(2,2-difluoroethoxy)-N-(5,8-dimethoxy[1,2,4]triazolo[1,5-c]pyrimidin-2-yl)-6-(trifluoromethyl)benzenesulfonamide | 組成式: | C16 H14 F5 N5 O5 S | SMILES: | FC(F)(F)c1cccc(OCC(F)F)c1S(=O)(=O)Nc2nc3c(OC)cnc(OC)n3n2 | InChi: | InChI=1S/C16H14F5N5O5S/c1-29-10-6-22-15(30-2)26-13(10)23-14(24-26)25-32(27,28)12-8(16(19,20)21)4-3-5-9(12)31-7-11(17)18/h3-6,11H,7H2,1-2H3,(H,24,25) | 別名: | Penoxsulam | 定義日: | 2014-06-05 | 最終更新日: | 2020-06-17 | 公開日: | 2018-02-14 | 識別子(ID): | 2-(2,2-difluoroethoxy)-N-(5,8-dimethoxy[1,2,4]triazolo[1,5-c]pyrimidin-2-yl)-6-(trifluoromethyl)benzenesulfonamide |
|